Chronic oral dipyridamole as a 'novel' antianginal drug: The collateral hypothesis

Cardiovascular Research

Volumn 33, Issue 3, 1997, Pages 666-670

  Picano, Eugenio ^a   Michelassi, Claudio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Adenosine; Collateral vessels; Dipyridamole; Myocardial ischemia

Indexed keywords

ADENOSINE; DIPYRIDAMOLE;

ANGINA PECTORIS; ARTICLE; COLLATERAL CIRCULATION; DRUG EFFICACY; HEART MUSCLE ISCHEMIA; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADENOSINE; ADMINISTRATION, ORAL; ANGINA PECTORIS; ANGIOGENESIS INDUCING AGENTS; CLINICAL TRIALS; COLLATERAL CIRCULATION; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; HUMANS; TIME FACTORS;

EID: 0031043210     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00262-3     Document Type: Article

References (48)

1. Fitzgerald GA. Dipyridamole. N Engl J Med 1987;316:1247-1257.
2. Ferguson JJ. Research News: Second European Stroke Prevention Study. Circulation 1996;93:399.
3. Sacks HS, Ancona-Berk VA, Berrier J, Nagalingam R, Chalmers TC. Dipyridamole in the treatment of angina pectoris: a meta-analysis. Clin Pharmacol Ther 1988;43:610-615.
4. Keitz TN, Innerfiled M, Gitler B, Cooper JA. Dipyridamole-induced myocardial ischemia. J Am Med Assoc 1987;257:1515-1516.
5. Castello R, Hidalgo R. Dipyridamole-induced myocardial ischemia (Letter). J Am Med Assoc 1988;259:1179.
6. Waters D. Proischemic complications of dihydropyridine calcium channel blockers. Circulation 1991;84:2598-2600.
7. Picano E. Dipyridamole-echocardiography test: the historical background and the physiologic basis. Eur Heart J 1989;10:365-376.
8. Schaper W, Sharma HS, Quinkler W, Markery T, Wunsch M, Schaper J. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 1990;15:513-518.
9. Kass RW, Kotler MN, Yazdanfar S. Stimulation of coronary collateral growth: current developments in angiogenesis and future clinical applications. Am Heart J 1992;123:486-496.
10. Meininger CJ, Schelling ME, Granger HJ. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 1988;255:H544-H562.
11. Meininger CJ, Granger HJ. Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol 1990;258:H198-H206.
12. Hashimoto E, Kage K, Ogita T, Nakaoka T, Matsuoka R, Kira Y. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun 1994;204:318-324.
13. Fischer S, Sharma HS, Karliczek GF, Schaper W. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol Brain Res 1995;28:141-148.
14. Mattfeldt T, Mal G. Dipyridamole-induced capillary endothelial cell proliferation in the rat heart: a morphometric investigation. Cardiovasc Res 1983;17:229-237.
15. Tornling G. Capillary neoformation in the heart of dipyridamole-treated rats. Acta Pathol Microbiol Immunol Scand 1982;90:269-271.
16. Torry RJ, O'Brien DM, Connell PM, Tomanek RJ. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol 1992;262:H980-H986.
17. Symons JD, Firoozmand E, Longhurst JC. Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise. A role of adenosine. Circ Res 1993;73:503-513.
18. Khouri EM, Gregg DE, McGranahan GM. Regression and reappearance of coronary collaterals. Am J Physiol 1971;220;655.
19. Becker MC. Angina pectoris: a double-blind study with dipyridamole. J Newark Beth Israel Hosp 1967;18:88-94.
20. Igloe MC. Treatment of angina pectoris with dipyridamole: a double-blind study. J Am Geriatr Soc 1970;18:233-241.
21. Sbar S, Schlant RC. Dipyridamole in the treatment of angina pectoris. J Am Med Assoc 1967;201:865-867.
22. Zion MM, Bradlow BA. A controlled clinical trial of 'Persantin' (RA8) in angina pectoris. South Afr Med J 1961;35:11-13.
23. Dewar HA, Horler AR. A clinical trial of Persantin and crodimyl in the treatment of angina of effort. Scot Med J 1961;6:149-152.
24. Kinsella D, Troup W, McGregor M. Studies with a new coronary vasodilator drug: Persantin. Am Heart J 1962;63:146-151.
25. Wirecki M. Treatment of angina pectoris with dipyridamole: a long-term double-blind study. J Chronic Dis 1967;20:139-145.
26. Foulds T, Mackinnon J. Controlled double-blind trial of 'Persantin' in treatment of angina pectoris. Br Med J 1960;2:835.
27. Leiberman A, Guglielmelli S. Persantin: a double-blind study. Angiology 1964;15:290-292.
28. Neumann M, Luisada AA. Effect of rapid-and slow-acting 'coronary' drugs on precordial pain of the aged. Am 3 Med Sci 1964;247:156-163.
29. Tsuya T, Okada M, Horie H, Ishikawa K. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. Am J Cardiol 1990;66:275-278.
30. McFarland Barbour M, Ewing Garber W, Agarwal KC, Malhotra R, Heller GV. Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy. Am J Cardiol 1992;69:449-452.
31. Maseri A. Experimental models of acute myocardial ischemia. In: Maseri A, ed. Ischemic Heart Disease. London: Churchill Livingstone, 1995;139-162.
32. Lawson WE, Hui JCK, Soroff HS, et al. Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992;70:859-862.
33. Schaper W. The Collateral Circulation of the Heart. New York: Elsevier, 1971.
34. Iba T, Sumpio BE. Morphological response of human endothelial cells subjected to cyclic strain in vitro. Microvasc Res 1991;42:245-254.
35. Iba T, Maitz S, Furber T, et al. Effect of cyclic stretch on endothelial cells from different vascular beds. Circ Shock 1991;35:193-198.
36. Schaper W. New paradigms for collateral vessel growth. Basic Res Cardiol 1993;88:193-198.
37. Rowe GG. Inequalities of myocardial perfusion in experimental myocardial ischemia (coronary steal). Circulation 1970;42:193-194.
38. Fam WM, McGregor M. Effect of coronary vasodilator drugs on retrograde flow in areas of chronic myocardial ischemia. Circ Res 1964;15:355-360.
39. Picano E, Parodi O, Lattanzi F, et al. Assessment of anatomic and physiologic severity of single vessel coronary artery lesions by dipyridamole echocardiography: comparison with positron emission tomography and quantitative arteriography. Circulation 1994;89:753-757.
40. Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Point of view. Circulation 1992;85(4):1604-1612.
41. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8:848-854.
42. Picano E, Ostojic M, Varga A, Sicari R, Djordevic-Dikic A, Nedeljkovic I, Torres M. Combined low dose dipyridamole-dobutamine echocardiography: a new stress for myocardial viability identification by pharmacological stress echocardiography. J Am Coll Cardiol 1996;27:1142-1148.
43. Loeb HS, Danoviz J, Miller A, Gunnar RM. Effects of oral dipyridamole on coronary dynamics and myocardial metabolism at rest and during pacing-induced angina in patients with coronary artery disease. Am Heart J 1983;105:906-914.
44. Bjornsson TD, Mahony C. Clinical pharmacokinetics of dipyridamole. Thromb Res 1983;suppl IV:93-104.
45. Homma S, Callahan RJ, Ameer B, et al. Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease. Am J Cardiol 1986;57:503-508.
46. Sylven C, Beerman B, Jonzon B, et al. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J 1986;293:227.
47. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 1991;83:1256-1262.
48. Schaper W. Collateral vessel growth in the human heart. Role of fibroblast growth factor-2. Circulation 1996;94:600-601.